Lyon, France – Gentilly, France – Austin, Texas, United States – June 9, 2026 – 8:00 am CEST – On the occasion of International Batten Disease Awareness Day happening today, THX Pharma (Theranexus), a biopharmaceutical company specializing in the development of innovative treatments for rare neurological diseases, Biocodex, an independent international pharmaceutical group and long-time pioneer in the treatment of rare pediatric diseases, and the Beyond Batten Disease Foundation (BBDF), a patient-founded non-profit dedicated to eradicating juvenile Batten disease, today reaffirm their shared commitment to the patients, families, caregivers and clinicians affected by CLN3 Batten disease.
View the Full Press Release